Cotinga Pharmaceuticals P/E
Quel est le P/E de Cotinga Pharmaceuticals?
Le P/E de Cotinga Pharmaceuticals, Inc. est N/A
Quelle est la définition de P/E?
Le ratio cours / bénéfice est le rapport entre le prix des actions d'une entreprise et le bénéfice par action de l'entreprise calculé sur les douze derniers mois.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E des entreprises dans Health Care secteur sur TSXV par rapport à Cotinga Pharmaceuticals
Que fait Cotinga Pharmaceuticals?
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
Entreprises avec p/e similaire à Cotinga Pharmaceuticals
- InvoCare a P/E de N/A
- Argen X SE a P/E de N/A
- Indiabulls Ventures a P/E de N/A
- Kokuyo Camlin a P/E de N/A
- Hong Kong Television Network a P/E de N/A
- Biocorp Production a P/E de N/A
- Cotinga Pharmaceuticals a P/E de N/A
- Tailam Tech Constr Hldg Ltd a P/E de N/A
- MPC Münchmeyer Petersen Capital AG a P/E de N/A
- MAG Silver a P/E de N/A
- Hays plc a P/E de N/A
- Two Shields Investments Plc a P/E de N/A
- MAG Silver a P/E de N/A